Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group BSILVERMAN, Lewis R; DEMAKOS, Erin P; ELLERTON, John et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2429-2440, issn 0732-183XArticle

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A Cancer and Leukemia Group B studyKORNBLITH, Alice B; HERNDON, James E; SCHIFFER, Charles A et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2441-2452, issn 0732-183XArticle

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignanciesFANDY, Tamer E; HERMAN, James G; LICHT, Jonathan et al.Blood. 2009, Vol 114, Num 13, pp 2764-2773, issn 0006-4971, 10 p.Article